Jump to main content
Jump to site search

Issue 57, 2020
Previous Article Next Article

LMCT transition-based red-light photochemotherapy using a tumour-selective ferrocenyl iron(iii) coumarin conjugate

Author affiliations

Abstract

A rationally designed iron(III) complex (2a) with pendant ferrocene and naturally occurring coumarin (esculetin) shows LMCT transition-based mitochondria-targeted red-light (600–720 nm) induced apoptotic toxicity against cancer cells but remains innocuous in the dark and to normal cells.

Graphical abstract: LMCT transition-based red-light photochemotherapy using a tumour-selective ferrocenyl iron(iii) coumarin conjugate

Back to tab navigation

Supplementary files

Article information


Submitted
05 May 2020
Accepted
29 May 2020
First published
15 Jun 2020

Chem. Commun., 2020,56, 7981-7984
Article type
Communication

LMCT transition-based red-light photochemotherapy using a tumour-selective ferrocenyl iron(III) coumarin conjugate

T. Sarkar, A. Bhattacharyya, S. Banerjee and A. Hussain, Chem. Commun., 2020, 56, 7981
DOI: 10.1039/D0CC03240A

Social activity

Search articles by author

Spotlight

Advertisements